Robust risk prediction with biomarkers under two-phase stratified cohort design
From MaRDI portal
Publication:5355221
Recommendations
- Evaluating the predictive value of biomarkers with stratified case-cohort design
- Nonparametric maximum likelihood estimators of time-dependent accuracy measures for survival outcome under two-stage sampling designs
- Adopting nested case-control quota sampling designs for the evaluation of risk markers
- Improving efficiency in biomarker incremental value evaluation under two-phase designs
- Kernel machine testing for risk prediction with stratified case cohort studies
Cited in
(11)- Prediction of dementia using screening and diagnosis history in longitudinal two-phase studies
- A tutorial on dynamic risk prediction of a binary outcome based on a longitudinal biomarker
- Evaluating the predictive value of biomarkers with stratified case-cohort design
- Model-free scoring system for risk prediction with application to hepatocellular carcinoma study
- Nonparametric maximum likelihood estimators of time-dependent accuracy measures for survival outcome under two-stage sampling designs
- Adopting nested case-control quota sampling designs for the evaluation of risk markers
- Conditional concordance-assisted learning under matched case-control design for combining biomarkers for population screening
- Assessing incremental value of biomarkers with multi-phase nested case-control studies
- Kernel machine testing for risk prediction with stratified case cohort studies
- Subgroup specific incremental value of new markers for risk prediction
- A semiparametric method for risk prediction using integrated electronic health record data
This page was built for publication: Robust risk prediction with biomarkers under two-phase stratified cohort design
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5355221)